Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 294

1.

FAMILIES: an effective healthcare intervention for caregivers of community dwelling people living with dementia.

Sperling SA, Brown DS, Jensen C, Inker J, Mittelman MS, Manning CA.

Aging Ment Health. 2019 Jul 31:1-9. doi: 10.1080/13607863.2019.1647141. [Epub ahead of print]

PMID:
31364866
2.

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.

Hoeks M, Yu G, Langemeijer S, Crouch S, de Swart L, Fenaux P, Symeonidis A, Čermák J, Hellström-Lindberg E, Sanz G, Stauder R, Holm MS, Mittelman M, Mądry K, Malcovati L, Tatic A, Almeida AM, Germing U, Savic A, Gredelj Šimec N, Culligan D, Itzykson R, Guerci-Bresler A, Slama B, van de Loosdrecht A, van Marrewijk C, Droste J, Blijlevens N, van Kraaij M, Bowen D, de Witte T, Smith A; EUMDS Registry Participants.

Haematologica. 2019 Jul 5. pii: haematol.2018.212332. doi: 10.3324/haematol.2018.212332. [Epub ahead of print]

3.

Helping Hispanic Family Caregivers of Persons With Dementia "Get the Picture" About Health Status Through Tailored Infographics.

Arcia A, Suero-Tejeda N, Spiegel-Gotsch N, Luchsinger JA, Mittelman M, Bakken S.

Gerontologist. 2019 Jun 11. pii: gnz085. doi: 10.1093/geront/gnz085. [Epub ahead of print]

PMID:
31185098
4.

Impact of red blood cell transfusion dose density on progression-free survival in lower-risk myelodysplastic syndromes patients.

de Swart L, Crouch S, Hoeks M, Smith A, Langemeijer S, Fenaux P, Symeonidis A, Čermák J, Hellström-Lindberg E, Stauder R, Sanz G, Mittelman M, Holm MS, Malcovati L, Mądry K, Germing U, Tatic A, Savic A, Almeida AM, Gredelj-Šimec N, Guerci-Bresler A, Beyne-Rauzy O, Culligan D, Kotsianidis I, Itzykson R, van Marrewijk C, Blijlevens N, Bowen D, de Witte T; EUMDS Registry Participants.

Haematologica. 2019 Jun 6. pii: haematol.2018.212217. doi: 10.3324/haematol.2018.212217. [Epub ahead of print]

5.

Reprint of: Comments on duodenoscope reprocessing study.

Mittelman MW, Steffey D.

Gastrointest Endosc. 2019 Apr;89(4):907. doi: 10.1016/j.gie.2019.02.005. No abstract available.

PMID:
30902222
6.

Comments on duodenoscope reprocessing study.

Mittelman MW, Steffey D.

Gastrointest Endosc. 2019 Feb;89(2):442-443. doi: 10.1016/j.gie.2018.08.035. No abstract available.

PMID:
30665536
7.

The effects of information and communication technologies on informal caregivers of persons living with dementia: A systematic review.

Lucero RJ, Fehlberg EA, Patel AGM, Bjarnardottir RI, Williams R, Lee K, Ansell M, Bakken S, Luchsinger JA, Mittelman M.

Alzheimers Dement (N Y). 2018 Dec 31;5:1-12. doi: 10.1016/j.trci.2018.11.003. eCollection 2019.

8.

Predictors of the personal benefits and positive aspects of informal caregiving.

Pendergrass A, Mittelman M, Graessel E, Özbe D, Karg N.

Aging Ment Health. 2018 Nov 14:1-6. doi: 10.1080/13607863.2018.1501662. [Epub ahead of print]

PMID:
30428698
9.

Patient commentary: Stop hyping artificial intelligence-patients will always need human doctors.

Mittelman M, Markham S, Taylor M.

BMJ. 2018 Nov 7;363:k4669. doi: 10.1136/bmj.k4669. No abstract available.

PMID:
30404859
10.

Myelodysplastic Syndromes Over Time: A Comparison of Two Patient Cohorts.

Oster HS, Svorai-Litvak S, Kirgner I, Kolomansky A, Siegel RS, Mittelman M.

Isr Med Assoc J. 2018 Oct;20(10):608-612.

11.

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia.

Dickinson M, Cherif H, Fenaux P, Mittelman M, Verma A, Portella MSO, Burgess P, Ramos PM, Choi J, Platzbecker U; SUPPORT study investigators.

Blood. 2018 Dec 20;132(25):2629-2638. doi: 10.1182/blood-2018-06-855221. Epub 2018 Oct 10.

12.

The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q).

Sekeres MA, Swern AS, Giagounidis A, List AF, Selleslag D, Mittelman M, Schlegelberger B, Göhring G, Li JS, Sugrue MM, Fenaux P.

Blood Cancer J. 2018 Sep 21;8(10):90. doi: 10.1038/s41408-018-0126-z. No abstract available.

13.

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes.

Itzykson R, Crouch S, Travaglino E, Smith A, Symeonidis A, Hellström-Lindberg E, Sanz G, Čermák J, Stauder R, Elena C, Germing U, Mittelman M, Langemeijer S, Mądry K, Tatic A, Holm MS, Almeida AM, Savic A, Šimec NG, Luño E, Culligan D, Guerci-Bresler A, Malcovati L, van Marrewijk C, Bowen D, de Witte T, Fenaux P; European MDS Registry members.

Blood Adv. 2018 Aug 28;2(16):2079-2089. doi: 10.1182/bloodadvances.2018020495.

14.

Comparative Effectiveness of 2 Interventions for Hispanic Caregivers of Persons with Dementia.

Luchsinger JA, Burgio L, Mittelman M, Dunner I, Levine JA, Hoyos C, Tipiani D, Henriquez Y, Kong J, Silver S, Ramirez M, Teresi JA.

J Am Geriatr Soc. 2018 Sep;66(9):1708-1715. doi: 10.1111/jgs.15450. Epub 2018 Aug 7.

PMID:
30084133
15.

The Effects of a Comprehensive Psychosocial Intervention on Secondary Stressors and Social Support for Adult Child Caregivers of Persons With Dementia.

Gaugler JE, Reese M, Mittelman MS.

Innov Aging. 2018 Jun;2(2):igy015. doi: 10.1093/geroni/igy015. Epub 2018 Jun 22.

16.

Thrombocytopenia in Patients with Myelodysplastic Syndromes: Still an Unsolved Problem.

Basood M, Oster HS, Mittelman M.

Mediterr J Hematol Infect Dis. 2018 Jul 1;10(1):e2018046. doi: 10.4084/MJHID.2018.046. eCollection 2018. Review.

17.

Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?

Greenbaum U, Joffe E, Filanovsky K, Oster HS, Kirgner I, Levi I, Raanani P, Avivi I, Manor E, Man-El G, Mittelman M.

Eur J Haematol. 2018 Oct;101(4):502-507. doi: 10.1111/ejh.13134. Epub 2018 Aug 31.

PMID:
29956845
18.

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study.

Stauder R, Yu G, Koinig KA, Bagguley T, Fenaux P, Symeonidis A, Sanz G, Cermak J, Mittelman M, Hellström-Lindberg E, Langemeijer S, Holm MS, Mądry K, Malcovati L, Tatic A, Germing U, Savic A, van Marrewijk C, Guerci-Bresler A, Luño E, Droste J, Efficace F, Smith A, Bowen D, de Witte T.

Leukemia. 2018 Jun;32(6):1380-1392. doi: 10.1038/s41375-018-0089-x. Epub 2018 Mar 6.

19.

Process Evaluation of the NYU Caregiver Intervention-Adult Child.

Gaugler JE, Reese M, Mittelman MS.

Gerontologist. 2018 Mar 19;58(2):e107-e117. doi: 10.1093/geront/gnx048.

20.

Information, communication, and online tool needs of Hispanic family caregivers of individuals with Alzheimer's disease and related dementias.

Iribarren S, Stonbraker S, Suero-Tejeda N, Granja M, Luchsinger JA, Mittelman M, Bakken S, Lucero R.

Inform Health Soc Care. 2019;44(2):115-134. doi: 10.1080/17538157.2018.1433674. Epub 2018 Mar 5.

21.

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS.

de Swart L, Smith A, Haase D, Fenaux P, Symeonidis A, Cermak J, Sanz G, Stauder R, Mittelman M, Hellström-Lindberg E, Malcovati L, Langemeijer S, Skov-Holm M, Mądry K, Germing U, Almeida AM, Tatic A, Savic A, Šimec NG, van Marrewijk C, Guerci-Bresler A, Sanhes L, Luño E, Culligan D, Beyne-Rauzy O, Burgstaller S, Blijlevens N, Bowen D, de Witte T.

Leuk Res. 2018 Apr;67:21-26. doi: 10.1016/j.leukres.2018.01.022. Epub 2018 Jan 31.

22.

Good news for patients with myelodysplastic syndromes and thrombocytopenia.

Mittelman M.

Lancet Haematol. 2018 Mar;5(3):e100-e101. doi: 10.1016/S2352-3026(18)30017-6. Epub 2018 Jan 26. No abstract available.

PMID:
29396096
23.

The Unforgettables: a chorus for people with dementia with their family members and friends.

Mittelman MS, Papayannopoulou PM.

Int Psychogeriatr. 2018 Jun;30(6):779-789. doi: 10.1017/S1041610217001867. Epub 2018 Jan 29.

PMID:
29375037
24.

Is bone marrow examination always necessary to establish the diagnosis of myelodysplastic syndromes? A proposed non-invasive diagnostic model.

Oster HS, Carmi G, Kolomansky A, Joffe E, Kaye I, Kirgner I, Greenbaum U, Comaneshter D, Mittelman M.

Leuk Lymphoma. 2018 Sep;59(9):2227-2232. doi: 10.1080/10428194.2017.1416363. Epub 2018 Jan 2.

PMID:
29295649
25.

Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.

Mittelman M, Platzbecker U, Afanasyev B, Grosicki S, Wong RSM, Anagnostopoulos A, Brenner B, Denzlinger C, Rossi G, Nagler A, Garcia-Delgado R, Portella MSO, Zhu Z, Selleslag D.

Lancet Haematol. 2018 Jan;5(1):e34-e43. doi: 10.1016/S2352-3026(17)30228-4. Epub 2017 Dec 11.

PMID:
29241762
26.

Medicaid Savings From The New York University Caregiver Intervention for Families with Dementia.

Foldes SS, Moriarty JP, Farseth PH, Mittelman MS, Long KH.

Gerontologist. 2018 Mar 19;58(2):e97-e106. doi: 10.1093/geront/gnx077.

PMID:
29106531
27.

Effect of Maladaptive Beliefs and Attitudes about Sleep among Community-dwelling African American Men at Risk for Obstructive Sleep Apnea.

Williams NJ, Jean-Louis G, Ceïde ME, Pandey A, Osorio R, Mittelman M, McFarlane SI.

J Sleep Disord Ther. 2017 Jun;6(3). pii: 269. doi: 10.4172/2167-0277.1000269. Epub 2017 May 20.

28.

Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).

Fenaux P, Giagounidis A, Selleslag D, Beyne-Rauzy O, Mittelman M, Muus P, Nimer SD, Hellström-Lindberg E, Powell BL, Guerci-Bresler A, Sekeres MA, Deeg HJ, Del Cañizo C, Greenberg PL, Shammo JM, Skikne B, Yu X, List AF.

J Hematol Oncol. 2017 Jun 26;10(1):131. doi: 10.1186/s13045-017-0491-2.

29.

External Validity of the New York University Caregiver Intervention: Key Caregiver Outcomes Across Multiple Demonstration Projects.

Fauth EB, Jackson MA, Walberg DK, Lee NE, Easom LR, Alston G, Ramos A, Felten K, LaRue A, Mittelman M.

J Appl Gerontol. 2019 Sep;38(9):1253-1281. doi: 10.1177/0733464817714564. Epub 2017 Jun 23.

PMID:
28645235
30.

Feasibility and Utility of Online Dementia Care Training for Hospital Staff: The CARES® Dementia-Friendly Hospital Program.

Hobday JV, Gaugler JE, Mittelman MS.

Res Gerontol Nurs. 2017 Mar 1;10(2):58-65. doi: 10.3928/19404921-20170131-01. Epub 2017 Feb 2.

31.

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome.

Garelius HK, Johnston WT, Smith AG, Park S, de Swart L, Fenaux P, Symeonidis A, Sanz G, Čermák J, Stauder R, Malcovati L, Mittelman M, van de Loosdrecht AA, van Marrewijk CJ, Bowen D, Crouch S, de Witte TJ, Hellström-Lindberg E.

J Intern Med. 2017 Mar;281(3):284-299. doi: 10.1111/joim.12579. Epub 2016 Dec 7.

32.

Northern Manhattan Hispanic Caregiver Intervention Effectiveness Study: protocol of a pragmatic randomised trial comparing the effectiveness of two established interventions for informal caregivers of persons with dementia.

Luchsinger JA, Burgio L, Mittelman M, Dunner I, Levine JA, Kong J, Silver S, Ramirez M, Teresi JA.

BMJ Open. 2016 Nov 25;6(11):e014082. doi: 10.1136/bmjopen-2016-014082. Erratum in: BMJ Open. 2016 Dec 28;6(12 ):e014082corr1.

33.

Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes.

Deshet-Unger N, Oster HS, Prutchi-Sagiv S, Maaravi N, Golishevski N, Neumann D, Mittelman M.

Leuk Res. 2017 Jan;52:20-27. doi: 10.1016/j.leukres.2016.11.002. Epub 2016 Nov 2.

PMID:
27870945
34.

Miscommunicating NOTA Can Be Costly to Living Donors.

Mittelman M, Thiessen C, Chon WJ, Clayville K, Cronin DC, Fisher JS, Fry-Revere S, Gross JA, Hanneman J, Henderson ML, Ladin K, Mysel H, Sherman LA, Willock L, Gordon EJ.

Am J Transplant. 2017 Feb;17(2):578-580. doi: 10.1111/ajt.14036. Epub 2016 Oct 3. No abstract available.

35.

Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol.

Mittelman M, Filanovsky K, Ofran Y, Rosenbaum H, Raanani P, Braester A, Goldschmidt N, Kirgner I, Herishanu Y, Perri C, Ellis M, Oster HS; Israel Myelodysplastic Syndrome Working Group (MDS-WG).

Ann Hematol. 2016 Oct;95(11):1811-8. doi: 10.1007/s00277-016-2776-x. Epub 2016 Aug 22.

PMID:
27546027
36.

Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss.

Deshet-Unger N, Hiram-Bab S, Haim-Ohana Y, Mittelman M, Gabet Y, Neumann D.

Sci Rep. 2016 Aug 2;6:30998. doi: 10.1038/srep30998.

37.

Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents.

Santini V, Almeida A, Giagounidis A, Gröpper S, Jonasova A, Vey N, Mufti GJ, Buckstein R, Mittelman M, Platzbecker U, Shpilberg O, Ram R, Del Cañizo C, Gattermann N, Ozawa K, Risueño A, MacBeth KJ, Zhong J, Séguy F, Hoenekopp A, Beach CL, Fenaux P.

J Clin Oncol. 2016 Sep 1;34(25):2988-96. doi: 10.1200/JCO.2015.66.0118. Epub 2016 Jun 27.

PMID:
27354480
38.

A Pure Life: The Microbial Ecology of High Purity Industrial Waters.

Mittelman MW, Jones ADG.

Microb Ecol. 2018 Jul;76(1):9-18. doi: 10.1007/s00248-016-0736-6. Epub 2016 Feb 15. Review.

PMID:
26879941
39.

Increased Incidence of Red Blood Cell Alloantibodies in Myelodysplastic Syndrome.

Rozovski U, Ben-Tal O, Kirgner I, Mittelman M, Hareuveni M.

Isr Med Assoc J. 2015 Oct;17(10):624-7.

40.

Music therapy: A nonpharmacological approach to the care of agitation and depressive symptoms for nursing home residents with dementia.

Ray KD, Mittelman MS.

Dementia (London). 2017 Aug;16(6):689-710. doi: 10.1177/1471301215613779. Epub 2015 Oct 29.

PMID:
26519453
41.

Quality Improvement in Skilled Nursing Facilities for Residents With Alzheimer's Disease.

Farlow MR, Borson S, Connor SR, Grossberg GT, Mittelman MS.

Am J Alzheimers Dis Other Demen. 2016 Mar;31(2):156-62. doi: 10.1177/1533317515603501. Epub 2015 Sep 17.

PMID:
26385946
42.

Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural model.

Suttorp MM, Hoekstra T, Mittelman M, Ott I, Krediet RT, Dekker FW, Putter H.

Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1068-75. doi: 10.1002/pds.3855. Epub 2015 Aug 12.

PMID:
26265483
43.

Effects of the Minnesota Adaptation of the NYU Caregiver Intervention on Depressive Symptoms and Quality of Life for Adult Child Caregivers of Persons with Dementia.

Gaugler JE, Reese M, Mittelman MS.

Am J Geriatr Psychiatry. 2015 Nov;23(11):1179-92. doi: 10.1016/j.jagp.2015.06.007. Epub 2015 Jun 25.

44.

Inaugural osher integrative medicine research forum: an overview.

Mittelman M, Duffy L.

Glob Adv Health Med. 2015 Mar;4(2):17-20. doi: 10.7453/gahmj.2015.023. No abstract available.

45.

Immunosuppressive Therapy in Myelodysplastic Syndromes Is Still Alive.

Mittelman M, Oster HS.

Acta Haematol. 2015;134(3):135-7. doi: 10.1159/000371833. Epub 2015 Apr 24. No abstract available.

PMID:
25925850
46.

Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndrome.

Ofran Y, Filanovsky K, Gafter-Gvili A, Vidal L, Aviv A, Gatt ME, Silbershatz I, Herishanu Y, Arad A, Tadmor T, Dally N, Nemets A, Rouvio O, Ronson A, Herzog-Tzarfati K, Akria L, Braester A, Hellmann I, Yeganeh S, Nagler A, Leiba R, Mittelman M, Merkel D.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):e95-9. doi: 10.1016/j.clml.2015.02.030. Epub 2015 Mar 5.

PMID:
25819366
47.

Health coaching: an update on the national consortium for credentialing of health & wellness coaches.

Mittelman M.

Glob Adv Health Med. 2015 Jan;4(1):68-75. doi: 10.7453/gahmj.2014.062.

48.

Characteristics and mental health of Hispanic dementia caregivers in New York City.

Luchsinger JA, Tipiani D, Torres-Patiño G, Silver S, Eimicke JP, Ramirez M, Teresi J, Mittelman M.

Am J Alzheimers Dis Other Demen. 2015 Sep;30(6):584-90. doi: 10.1177/1533317514568340. Epub 2015 Jan 29.

49.

Erythropoietin directly stimulates osteoclast precursors and induces bone loss.

Hiram-Bab S, Liron T, Deshet-Unger N, Mittelman M, Gassmann M, Rauner M, Franke K, Wielockx B, Neumann D, Gabet Y.

FASEB J. 2015 May;29(5):1890-900. doi: 10.1096/fj.14-259085. Epub 2015 Jan 28.

PMID:
25630969
50.

Effects of the Minnesota Adaptation of the NYU Caregiver Intervention on Primary Subjective Stress of Adult Child Caregivers of Persons With Dementia.

Gaugler JE, Reese M, Mittelman MS.

Gerontologist. 2016 Jun;56(3):461-74. doi: 10.1093/geront/gnu125. Epub 2015 Jan 27.

Supplemental Content

Loading ...
Support Center